Clinical trial NCT02665546 - References

Langerhans Cell Histiocytosis — Evaluation of Exercise Capacity and Exercise Limitation in Patients With Pulmonary Langerhans Cell Histiocytosis

Citation(s)

•   Abbritti M, Mazzei MA, Bargagli E, Refini RM, Penza F, Perari MG, Volterrani L, Rottoli P
  Utility of spiral CAT scan in the follow-up of patients with pulmonary Langerhans cell histiocytosis. Eur J Radiol. 2012 Aug;81(8):1907-12. doi: 10.1016/j.ejrad.2011.04.018. Epub 2011 May 6.
•   Aerni MR, Aubry MC, Myers JL, Vassallo R
  Complete remission of nodular pulmonary Langerhans cell histiocytosis lesions induced by 2-chlorodeoxyadenosine in a non-smoker. Respir Med. 2008 Feb;102(2):316-9. Epub 2007 Nov 1.
•   Attili AK, Kazerooni EA, Gross BH, Flaherty KR, Myers JL, Martinez FJ
  Smoking-related interstitial lung disease: radiologic-clinical-pathologic correlation. Radiographics. 2008 Sep-Oct;28(5):1383-96; discussion 1396-8. doi: 10.1148/rg.285075223. Review.
•   Bendayan D, Shitrit D, Kramer MR
  Combination therapy with prostacyclin and tadalafil for severe pulmonary arterial hypertension: a pilot study. Respirology. 2008 Nov;13(6):916-8. doi: 10.1111/j.1440-1843.2007.01176.x.
•   Benyounes B, Crestani B, Couvelard A, Vissuzaine C, Aubier M
  Steroid-responsive pulmonary hypertension in a patient with Langerhans' cell granulomatosis (histiocytosis X). Chest. 1996 Jul;110(1):284-6.
•   Caminati A, Cavazza A, Sverzellati N, Harari S
  An integrated approach in the diagnosis of smoking-related interstitial lung diseases. Eur Respir Rev. 2012 Sep 1;21(125):207-17. doi: 10.1183/09059180.00003112.
•   Dauriat G, Mal H, Thabut G, Mornex JF, Bertocchi M, Tronc F, Leroy-Ladurie F, Dartevelle P, Reynaud-Gaubert M, Thomas P, Pison C, Blin D, Stern M, Bonnette P, Dromer C, Velly JF, Brugière O, Lesèche G, Fournier M
  Lung transplantation for pulmonary langerhans' cell histiocytosis: a multicenter analysis. Transplantation. 2006 Mar 15;81(5):746-50.
•   Fartoukh M, Humbert M, Capron F, Maître S, Parent F, Le Gall C, Sitbon O, Hervé P, Duroux P, Simonneau G
  Severe pulmonary hypertension in histiocytosis X. Am J Respir Crit Care Med. 2000 Jan;161(1):216-23.
•   Fukuda Y, Miura S, Fujimi K, Yano M, Nishikawa H, Yanagisawa J, Hiratsuka M, Shiraishi T, Iwasaki A, Saku K
  Effects of treatment with a combination of cardiac rehabilitation and bosentan in patients with pulmonary Langerhans cell histiocytosis associated with pulmonary hypertension. Eur J Prev Cardiol. 2014 Dec;21(12):1481-3. doi: 10.1177/2047487313497603. Epub 2013 Jul 29.
•   Hoeper MM, Bogaard HJ, Condliffe R, Frantz R, Khanna D, Kurzyna M, Langleben D, Manes A, Satoh T, Torres F, Wilkins MR, Badesch DB
  Definitions and diagnosis of pulmonary hypertension. J Am Coll Cardiol. 2013 Dec 24;62(25 Suppl):D42-50. doi: 10.1016/j.jacc.2013.10.032. Review.
•   Kiakouama L, Cottin V, Etienne-Mastroïanni B, Khouatra C, Humbert M, Cordier JF
  Severe pulmonary hypertension in histiocytosis X: long-term improvement with bosentan. Eur Respir J. 2010 Jul;36(1):202-4. doi: 10.1183/09031936.00004810.
•   Le Pavec J, Lorillon G, Jaïs X, Tcherakian C, Feuillet S, Dorfmüller P, Simonneau G, Humbert M, Tazi A
  Pulmonary Langerhans cell histiocytosis-associated pulmonary hypertension: clinical characteristics and impact of pulmonary arterial hypertension therapies. Chest. 2012 Nov;142(5):1150-1157. doi: 10.1378/chest.11-2490.
•   Lorillon G, Bergeron A, Detourmignies L, Jouneau S, Wallaert B, Frija J, Tazi A
  Cladribine is effective against cystic pulmonary Langerhans cell histiocytosis. Am J Respir Crit Care Med. 2012 Nov 1;186(9):930-2.
•   Mason RH, Foley NM, Branley HM, Adamali HI, Hetzel M, Maher TM, Suntharalingam J
  Pulmonary Langerhans cell histiocytosis (PLCH): a new UK register. Thorax. 2014 Aug;69(8):766-7. doi: 10.1136/thoraxjnl-2013-204313. Epub 2014 Jan 30.
•   Mendez JL, Nadrous HF, Vassallo R, Decker PA, Ryu JH
  Pneumothorax in pulmonary Langerhans cell histiocytosis. Chest. 2004 Mar;125(3):1028-32.
•   Paciocco G, Uslenghi E, Bianchi A, Mazzarella G, Roviaro GC, Vecchi G, Harari S
  Diffuse cystic lung diseases: correlation between radiologic and functional status. Chest. 2004 Jan;125(1):135-42.
•   Ryu JH, Tian X, Baqir M, Xu K
  Diffuse cystic lung diseases. Front Med. 2013 Sep;7(3):316-27. doi: 10.1007/s11684-013-0269-z. Epub 2013 May 11. Review.
•   Seeger W, Adir Y, Barberà JA, Champion H, Coghlan JG, Cottin V, De Marco T, Galiè N, Ghio S, Gibbs S, Martinez FJ, Semigran MJ, Simonneau G, Wells AU, Vachiéry JL
  Pulmonary hypertension in chronic lung diseases. J Am Coll Cardiol. 2013 Dec 24;62(25 Suppl):D109-16. doi: 10.1016/j.jacc.2013.10.036. Review.
•   Seely JM, Salahudeen S Sr, Cadaval-Goncalves AT, Jamieson DH, Dennie CJ, Matzinger FR, Souza CA
  Pulmonary Langerhans cell histiocytosis: a comparative study of computed tomography in children and adults. J Thorac Imaging. 2012 Jan;27(1):65-70. doi: 10.1097/RTI.0b013e3181f49eb6.
•   Soler P, Bergeron A, Kambouchner M, Groussard O, Brauner M, Grenier P, Crestani B, Mal H, Tazi A, Battesti JP, Loiseau P, Valeyre D
  Is high-resolution computed tomography a reliable tool to predict the histopathological activity of pulmonary Langerhans cell histiocytosis? Am J Respir Crit Care Med. 2000 Jul;162(1):264-70.
•   Task Force for Diagnosis and Treatment of Pulmonary Hypertension of European Society of Cardiology (ESC); European Respiratory Society (ERS); International Society of Heart and Lung Transplantation (ISHLT), Galiè N, Hoeper MM, Humbert M, Torbicki A, Vachiery JL, Barbera JA, Beghetti M, Corris P, Gaine S, Gibbs JS, Gomez-Sanchez MA, Jondeau G, Klepetko W, Opitz C, Peacock A, Rubin L, Zellweger M, Simonneau G
  Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J. 2009 Dec;34(6):1219-63. doi: 10.1183/09031936.00139009. Epub 2009 Sep 12.
•   Tazi A
  Adult pulmonary Langerhans' cell histiocytosis. Eur Respir J. 2006 Jun;27(6):1272-85. Review.
•   Torre O, Harari S
  The diagnosis of cystic lung diseases: a role for bronchoalveolar lavage and transbronchial biopsy? Respir Med. 2010 Jul;104 Suppl 1:S81-5. doi: 10.1016/j.rmed.2010.03.021. Epub 2010 Apr 28.
•   Vassallo R, Ryu JH, Schroeder DR, Decker PA, Limper AH
  Clinical outcomes of pulmonary Langerhans'-cell histiocytosis in adults. N Engl J Med. 2002 Feb 14;346(7):484-90.

Evaluation of Exercise Capacity and Mechanisms of Exercise Limitation in Patients With Pulmonary Langerhans Cell Histiocytosis

Details for clinical trial NCT02665546